blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1694260

EP1694260 - METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.05.2018
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  09.06.2017
FormerGrant of patent is intended
Status updated on  07.06.2017
FormerExamination is in progress
Status updated on  19.04.2017
FormerGrant of patent is intended
Status updated on  29.11.2016
Most recent event   Tooltip29.05.2020Lapse of the patent in a contracting state
New state(s): PT		published on 01.07.2020  [2020/27]
Applicant(s)For all designated states
ACURA PHARMACEUTICALS, INC.
616 N. Court
Palatine, IL 60067 / US
[2006/35]
Inventor(s)01 / KUMAR, Vijai
67 Whitewood Drive
Morris Plains, NJ 07950 / US
02 / DIXON, David
52-30 39th Drive
Woodside, NY 11377 / US
03 / TEWARI, Divya
106 Berkeley Square
Suffern, NY 10901 / US
04 / WADGAONKAR, Dilip, B.
1 Sycamore Lane
Suffern, NY 10901 / US
 [2006/35]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2017/28]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2006/35]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date04812083.623.11.2004
[2006/35]
WO2004US39490
Priority number, dateUS2003072365426.11.2003         Original published format: US 723654
[2006/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005053587
Date:16.06.2005
Language:EN
[2005/24]
Type: A1 Application with search report 
No.:EP1694260
Date:30.08.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 16.06.2005 takes the place of the publication of the European patent application.
[2006/35]
Type: B1 Patent specification 
No.:EP1694260
Date:12.07.2017
Language:EN
[2017/28]
Search report(s)International search report - published on:US16.06.2005
(Supplementary) European search report - dispatched on:EP20.08.2008
ClassificationIPC:A61K9/20
[2008/38]
CPC:
A61K31/485 (EP,US); A61K47/32 (US); A61K47/34 (US);
A61K47/38 (US); A61K9/2009 (EP,US); A61K9/2013 (US);
A61K9/2027 (EP,US); A61K9/2031 (EP,US); A61K9/2059 (US);
A61K9/2095 (US); A61K9/2853 (US); A61K9/2866 (EP,US);
A61K9/2893 (US); A61P25/04 (EP); A61P25/36 (EP) (-)
Former IPC [2006/35]A61F13/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/28]
Former [2006/35]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VERFAHREN UND ZUSAMMENSETZUNGEN ZUR VERHINDERUNG DES MISSBRAUCHS VON OPIOID-HALTIGEN DARREICHUNGSFORMEN[2017/25]
English:METHODS AND COMPOSITIONS FOR DETERRING ABUSE OF OPIOID CONTAINING DOSAGE FORMS[2006/35]
French:PROCEDES ET COMPOSITIONS POUR EMPECHER UN ABUS DE FORMES PHARMACEUTIQUES CONTENANT DES OPIOIDES[2006/35]
Former [2006/35]VERFAHREN UND ZUSAMMENSETZUNGEN ZUR VERHINDERUNG DES MISSBRAUCHS VON OPIOID-HALTIGEN DOSIERFORMEN
Entry into regional phase26.06.2006National basic fee paid 
26.06.2006Search fee paid 
26.06.2006Designation fee(s) paid 
26.06.2006Examination fee paid 
Examination procedure27.06.2005Request for preliminary examination filed
International Preliminary Examining Authority: US
26.06.2006Amendment by applicant (claims and/or description)
26.06.2006Examination requested  [2006/35]
05.03.2009Despatch of a communication from the examining division (Time limit: M04)
15.07.2009Reply to a communication from the examining division
02.02.2012Despatch of a communication from the examining division (Time limit: M06)
13.08.2012Reply to a communication from the examining division
22.05.2015Despatch of a communication from the examining division (Time limit: M04)
25.09.2015Reply to a communication from the examining division
22.09.2016Despatch of a communication from the examining division (Time limit: M02)
23.09.2016Reply to a communication from the examining division
30.11.2016Communication of intention to grant the patent
06.04.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
06.04.2017Fee for grant paid
06.04.2017Fee for publishing/printing paid
06.06.2017Information about intention to grant a patent
06.06.2017Receipt of the translation of the claim(s)
Divisional application(s)EP11158283.9  / EP2420225
EP11158284.7  / EP2402004
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.03.2009
Opposition(s)13.04.2018No opposition filed within time limit [2018/25]
Fees paidRenewal fee
26.06.2006Renewal fee patent year 03
30.11.2007Renewal fee patent year 04
25.11.2008Renewal fee patent year 05
25.11.2009Renewal fee patent year 06
24.11.2010Renewal fee patent year 07
23.11.2011Renewal fee patent year 08
26.11.2012Renewal fee patent year 09
27.11.2013Renewal fee patent year 10
26.11.2014Renewal fee patent year 11
30.11.2015Renewal fee patent year 12
28.11.2016Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.11.2004
AT12.07.2017
CY12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
PT12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
TR12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
IE23.11.2017
LU23.11.2017
BE30.11.2017
CH30.11.2017
LI30.11.2017
[2020/27]
Former [2020/15]HU23.11.2004
AT12.07.2017
CY12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
TR12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
IE23.11.2017
LU23.11.2017
BE30.11.2017
CH30.11.2017
LI30.11.2017
Former [2019/46]HU23.11.2004
AT12.07.2017
CY12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
IE23.11.2017
LU23.11.2017
BE30.11.2017
CH30.11.2017
LI30.11.2017
Former [2019/31]HU23.11.2004
AT12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
IE23.11.2017
LU23.11.2017
BE30.11.2017
CH30.11.2017
LI30.11.2017
Former [2018/50]AT12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
IE23.11.2017
LU23.11.2017
BE30.11.2017
CH30.11.2017
LI30.11.2017
Former [2018/45]AT12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
IE23.11.2017
LU23.11.2017
CH30.11.2017
LI30.11.2017
Former [2018/40]AT12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SI12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
LU23.11.2017
CH30.11.2017
LI30.11.2017
Former [2018/33]AT12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
MC12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
CH30.11.2017
LI30.11.2017
Former [2018/23]AT12.07.2017
CZ12.07.2017
DK12.07.2017
EE12.07.2017
FI12.07.2017
NL12.07.2017
PL12.07.2017
RO12.07.2017
SE12.07.2017
SK12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
Former [2018/21]AT12.07.2017
CZ12.07.2017
DK12.07.2017
FI12.07.2017
NL12.07.2017
PL12.07.2017
SE12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
Former [2018/11]AT12.07.2017
FI12.07.2017
NL12.07.2017
PL12.07.2017
SE12.07.2017
BG12.10.2017
GR13.10.2017
IS12.11.2017
Former [2018/10]AT12.07.2017
FI12.07.2017
NL12.07.2017
SE12.07.2017
Former [2018/09]FI12.07.2017
NL12.07.2017
SE12.07.2017
Former [2018/08]FI12.07.2017
NL12.07.2017
Documents cited:Search[XP] WO2004037259  (GRUENENTHAL GMBH et al.) [XP] 1-5,7,11-17,20,24-26 * page 16, paragraph 2 * * page 2 * * examples 1-29 * * claims 1-4,9-18 *
 [Y] US2003068371  (OSHLACK BENJAMIN et al.) [Y] 1-33 * paragraph [0024] - paragraph [0027] * * paragraph [0051] - paragraph [0053] * * examples 1-20 *
 [Y] EP1293195  (ROHM & HAAS et al.) [Y] 1-33 * claims 1,5 * * examples 1-4 *
 [Y] US2003124061  (ROBERTS RICHARD H et al.) [Y] 1-33 * claims 1,7-10 * * paragraph [0036] *
International search[X] US6375957  (KAIKO ROBERT F et al.)
 [X] US4599342  (LAHANN THOMAS R et al.)
by applicantUS6572885
   "Handbook of Pharmaceutical Excipients", 2003
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.